| CAS No | Product Name | Molecular Formula |
|---|---|---|
| 374936-69-3 | Methyl (5R)-5-{[(2S)-1-Methoxy-1-Oxo-2-Propanyl]Amino}-6-[(2-Methyl-2-Propanyl)Amino]-6-Oxohexanoate | C15H28N2O5 |
| 375345-95-2 | Mibampator | C21H30N2O4S2 |
| 375348-49-5 | Bertilimumab | |
| 375348-57-5 | (3Z)-3-(Hydroxymethylene)Furo[3,2-b]Furan-2(3H)-One | C7H4O4 |
| 375348-90-6 | (4S)-5-Ethoxy-4-[(2R)-1-Methyl-2-Pyrrolidinyl]Dihydro-2(3H)-Furanone | C11H19NO3 |
| 375348-91-7 | (4R)-5-Ethoxy-4-[(2R)-1-Methyl-2-Pyrrolidinyl]Dihydro-2(3H)-Furanone | C11H19NO3 |
| 375352-00-4 | 4-(Chloromethyl)-1,2-Dimethyl-1H-Imidazo[4,5-c]Pyridine | C9H10ClN3 |
| 375354-68-0 | 2-Amino-5,5-Dimethyl-4,5-Dihydro-6H-1,3,4-Thiadiazin-6-One | C5H9N3OS |
| 375357-45-2 | 6-[(2-Oxopropyl)Amino]Nicotinic Acid | C9H10N2O3 |
| 375359-83-4 | 1-(Chloroacetyl)-4-Piperidinecarboxamide | C8H13ClN2O2 |
| 375360-48-8 | 4-Chloro-N-Hydroxy-1,2,5-Oxadiazole-3-Carboximidamide | C3H3ClN4O2 |
| 375361-54-9 | (3-Formyl-2,2-Dimethylcyclopropyl)Acetonitrile | C8H11NO |
| 375363-74-9 | 1-(2-Imino-1(2H)-Pyridinyl)-2-Propanol | C8H12N2O |
| 375363-93-2 | 4-[(Hydroxymethyl)Amino]Benzaldehyde | C8H9NO2 |
| 375365-51-8 | 2-(2-Furylmethyleneamino)Acetic Acid | C7H7NO3 |
| 375368-78-8 | 3-Bromo-2-fluoro-6-methylpyridine | C6H5BrFN |
| 375368-80-2 | 3-Fluoro-2-methoxy-6-picoline | C7H8FNO |
| 375368-83-5 | 3-Bromo-6-fluoro-2-methylpyridine | C6H5BrFN |
| 375368-84-6 | 5-Chloro-2-fluoro-3-methylpyridine | C6H5ClFN |
| 375368-85-7 | 5-Cyano-2-fluoro-6-methylpyridine | C7H5FN2 |
| 375368-86-8 | 2-Methoxy-5-fluoro-6-methylpyridine | C7H8FNO |
| 375368-90-4 | Ethyl 2,3-Difluorocinnamate | C11H10F2O2 |
| 375368-92-6 | Ethyl 3,4-Difluorocinnamate | |
| 375368-94-8 | Tert-Butyl 3-Bromo-4-Fluorobenzoate | C11H12BrFO2 |
| 375369-03-2 | 4-Bromo-1H-indol-6-amine | C8H7BrN2 |
| 375369-14-5 | 6-Bromobenzoxazole | C7H4BrNO |
| 375369-29-2 | 2,4,5-Trifluoromandelic Acid | C8H5F3O3 |
| 375374-68-8 | [1,3,5]Triazocino[1,2-a]Benzimidazole | C11H8N4 |
| 375387-79-4 | N-[2-(2-Hydroxyethoxy)Ethyl]Glycine | C6H13NO4 |
| 375388-39-9 | 2-[(Dimethylsilyl)Oxy]Pyridine | C7H11NOSi |
| 375395-21-4 | 4-Methyl-1-Oxa-4-Azaspiro[2.4]Heptane-2-Carboxamide | C7H12N2O2 |
| 375395-33-8 | Trioctylmethylammonium bis(trifluoromethylsulfonyl)imide | C25H54N.C2F6NO4S2 |
| 375396-96-6 | 2-Isopropyl-5-Methyl-1-Benzofuran | C12H14O |
| 375397-36-7 | 2,6-Dimethoxyaniline, Hydrochloride | C8H12ClNO2 |
| 375792-69-1 | Methyl 2-Amino-3-Oxotetrahydro-1H-Pyrrolizine-7A(5H)-Carboxylate | C9H14N2O3 |
| 375806-77-2 | 2-Amino-5-Ethynylphenol | C8H7NO |
| 375815-87-5 | Varenicline tartrate | C13H13N3.C4H6O6 |
| 375819-04-8 | (1R,2R)-2-(Acetamidomethyl)Cyclopentyl Acetate | C10H17NO3 |
| 375819-05-9 | (1S,2R)-2-(Acetamidomethyl)Cyclopentyl Acetate | C10H17NO3 |
| 375819-08-2 | (1S,2S)-2-(Acetamidomethyl)Cyclopentyl Acetate | C10H17NO3 |
| 375819-09-3 | N-{[(1R,2R)-2-Hydroxycyclopentyl]Methyl}Acetamide | C8H15NO2 |
| 375819-10-6 | (1S,2R)-2-(Acetamidomethyl)Cyclopentyl Acetate | C10H17NO3 |
| 375819-11-7 | N-{[(1S,2R)-2-Hydroxycyclopentyl]Methyl}Acetamide | C8H15NO2 |
| 375819-12-8 | N-{[(1R,2S)-2-Hydroxycyclopentyl]Methyl}Acetamide | C8H15NO2 |
| 375822-19-8 | D-Ala-Lys-AMCA | C21H28N4O6 |
| 375823-41-9 | Tocilizumab | |
| 375824-96-7 | N-(2-Amino-4,5,6,7-Tetrahydro-Benzothiazol-6-Yl)-Propionamide | |
| 375825-10-8 | Ethyl (2S)-Tetrahydro-2-Furancarboxylate | C7H12O3 |
| 375825-11-9 | Ethyl Tetrahydro-2-Furancarboxylate | C7H12O3 |
| 375825-40-4 | 2-Fluoro-2,6,6-Trimethylcyclohexanone | C9H15FO |